Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 22, 2004Antimicrobial Agents and ChemotherapyOpen Access

In Vitro Activity of Anidulafungin against Selected Clinically Important Mold Isolates

View Full Paper
Ask AI
Bookmark
Share

Authors

ZOZekaver OdabaşıMarmara UniversityVPVictor L. PaetznickTexas Medical CenterJRJosé C. Rodríguez‐ReyUniversitat de Miguel Hernández d'Elx

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Odabaşı et al. (2004) studied this question.

synapsesocial.com/papers/6a865fffe7c8470ab14cab44https://doi.org/10.1128/aac.48.5.1912-1915.2004
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis2002 · 848 citations
  2. 2The Spectrum of Non-Candida Fungal Infections following Bone Marrow Transplantation1993 · 180 citations
  3. 3Production of IFN-? is impaired in patients with paracoccidioidomycosis during active disease and is restored after clinical remission2000 · 156 citations
  4. 4Comparison of In Vitro Activities of the New Triazole SCH56592 and the Echinocandins MK-0991 (L-743,872) and LY303366 against Opportunistic Filamentous and Dimorphic Fungi and Yeasts1998 · 577 citations
  5. 5In Vitro Activity of the Echinocandin Antifungal Agent LY303,366 in Comparison with Itraconazole and Amphotericin B against Aspergillus spp1998 · 87 citations